SS
JBIO

SBI Securities’s Jade Biosciences JBIO Stock Holding History

SBI Securities’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04K Buy
47
+29
+161% +$605 ﹤0.01% 2791
2026
Q1 		$253 Buy
18
+4
+29% +$58 ﹤0.01% 3129
2025
Q4 		$216 Sell
14
-13
-48% -$153 ﹤0.01% 3187
2025
Q3 		$233 Buy
27
+23
+575% +$188 ﹤0.01% 3264
2025
Q2 		$40 Buy
+4
New +$136 ﹤0.01% 3764

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SBI Securities's JBIO Position: Q2 2026 in Review

SBI Securities increased its Jade Biosciences (JBIO) stake by 161% in Q2 2026, buying an estimated $605 and bringing the position to 47 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #2791.

SBI Securities first reported a position in JBIO in Q2 2025 and has held it in 5 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • SBI Securities held 47 shares of Jade Biosciences worth $1.04K as of Q2 2026.
  • SBI Securities bought 29 Jade Biosciences shares in Q2 2026, an estimated $605.
  • Jade Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2791 holding.
  • SBI Securities first reported a position in Jade Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.